Trendaavat aiheet
#
Bonk Eco continues to show strength amid $USELESS rally
#
Pump.fun to raise $1B token sale, traders speculating on airdrop
#
Boop.Fun leading the way with a new launchpad on Solana.
Ruxandra Teslo 🧬
I come from Romanian peasant origins . My great grandma (who had 4 kids), an actual tradwife, not the current ballerina farm BS, would leave to work in the fields, away from her kids, for days on end. My grandma, who was 10, was left to supervise her younger siblings.
18.7. klo 04.50
Some of the 2 most controversial things I've said on Twitter turned out to be saying Lucy Letby's trial was probably unfair (early on) & recently suggesting some aspects of childcare should be automated. I think if childcare remains as time intensive as it is... bad news for TFR
13,85K
I come from Romanian peasant origins. My great grandma (who had 4 kids) would leave to work in the fields, away from her kids for days on end. My grandma, who was 10, was left to supervise her younger siblings -- and they revere her. Would you imagine this today?
18.7. klo 04.50
Some of the 2 most controversial things I've said on Twitter turned out to be saying Lucy Letby's trial was probably unfair (early on) & recently suggesting some aspects of childcare should be automated. I think if childcare remains as time intensive as it is... bad news for TFR
49
In Nov 2024, with @IFP and @RenPhil21, we realized that slow and inefficient trials were a key barrier to medical progress & launched the "Clinical Trial Abundance Initiative" -- a key theme we highlighted was FDA transparency & publishing CRL letters via @stuartbuck1's memo.
10.7. klo 21.05
Today, we're delivering on our promise of radical transparency. The FDA just published 200+ complete response letters—the actual decision letters we send to drug companies when applications need more work. No more guessing games. Developers, investors, and patients deserve to see how we make decisions.
16,02K
In Nov 2024, with @IFP and @RenPhil21 we IDed improving the speed/efficiency of clinical trials as a key driver of progress in medicine & launched the Clinical Trial Abundance initiative - stay tuned. @stuartbuck1 proposed this policy to improve FDA transparency & now it's here!
10.7. klo 21.05
Today, the FDA published more than 200 decision letters, known as complete response letters or CRLs.
CRLs are issued directly to product sponsors when the FDA completes its review cycle and determines that it cannot grant an approval of an application in its current form.
By making these CRLs available, the public now has significantly greater insight into the FDA’s decision-making and the most common deficiencies cited that sponsors must address before their application is approved.
4,83K
Johtavat
Rankkaus
Suosikit